MA28361A1 - Modulateurs des recepteurs d'androgenes - Google Patents

Modulateurs des recepteurs d'androgenes

Info

Publication number
MA28361A1
MA28361A1 MA29267A MA29267A MA28361A1 MA 28361 A1 MA28361 A1 MA 28361A1 MA 29267 A MA29267 A MA 29267A MA 29267 A MA29267 A MA 29267A MA 28361 A1 MA28361 A1 MA 28361A1
Authority
MA
Morocco
Prior art keywords
modulators
androgen receptors
androgen
receptors
Prior art date
Application number
MA29267A
Other languages
English (en)
Inventor
Lain-Yen Hu
Huangshu Lei
Daniel Yunlong Du
Bruce Allen Lefker
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MA28361A1 publication Critical patent/MA28361A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
MA29267A 2004-02-13 2006-08-11 Modulateurs des recepteurs d'androgenes MA28361A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54473804P 2004-02-13 2004-02-13
US60564704P 2004-08-30 2004-08-30

Publications (1)

Publication Number Publication Date
MA28361A1 true MA28361A1 (fr) 2006-12-01

Family

ID=34890476

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29267A MA28361A1 (fr) 2004-02-13 2006-08-11 Modulateurs des recepteurs d'androgenes

Country Status (20)

Country Link
US (1) US7576128B2 (fr)
EP (1) EP1716110A1 (fr)
JP (1) JP3997255B2 (fr)
KR (1) KR100783255B1 (fr)
AP (1) AP2006003700A0 (fr)
AR (1) AR047606A1 (fr)
AU (1) AU2005214167B2 (fr)
BR (1) BRPI0507670A (fr)
CA (1) CA2554696C (fr)
CR (1) CR8555A (fr)
EA (1) EA009902B1 (fr)
EC (1) ECSP066761A (fr)
IL (1) IL176935A0 (fr)
MA (1) MA28361A1 (fr)
NO (1) NO20064053L (fr)
PA (1) PA8623501A1 (fr)
PE (1) PE20051168A1 (fr)
TW (1) TW200534842A (fr)
UY (1) UY28746A1 (fr)
WO (1) WO2005080320A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1737813A1 (fr) 2004-04-13 2007-01-03 Warner-Lambert Company LLC Modulateurs d'androgenes
EP1740533A1 (fr) 2004-04-22 2007-01-10 Warner-Lambert Company LLC Modulateurs des androgenes
JP4874965B2 (ja) 2004-07-08 2012-02-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲン調節剤
CA2573457A1 (fr) * 2004-08-18 2006-02-23 Warner-Lambert Company Llc 4-(2-methoxyphenoxy)-2-trifluoromethylbenzonitrile pouvant servir de modulateur d'androgene
BRPI0514706A (pt) * 2004-08-31 2008-06-24 Warner Lambert Co moduladores de androgênio
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
TW200708499A (en) * 2005-06-22 2007-03-01 Warner Lambert Co Process for producing ethers
WO2007007149A1 (fr) * 2005-07-12 2007-01-18 Warner-Lambert Company Llc Modulateur d'androgene
US20090170886A1 (en) * 2005-08-08 2009-07-02 Pfizer Inc Androgen modulators
EP3108879A1 (fr) * 2015-06-25 2016-12-28 Cassiopea S.p.A. Formulation à concentration élevée
EP3833343B1 (fr) * 2018-08-07 2024-02-21 Emory University Dérivés hétérocycliques de flavone, compositions et procédés associés

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE298470C (fr)
US6124343A (en) 1919-01-27 2000-09-26 Rhone-Poulenc Rorer Limited Substituted phenyl compounds with a substituent having a thienyl ring
US3535365A (en) 1967-11-29 1970-10-20 Merck & Co Inc Preparation of 2,6-dichloro-4-methoxy-benzonitrile
DE2062349A1 (de) 1970-12-18 1972-06-29 Farbenfabriken Bayer Ag, 5090 Leverkusen Aminoaryloxy-ary!carbonsäurenitrile und ein Verfahren zu ihrer Herstellung
SU469247A3 (ru) 1972-01-14 1975-04-30 Майлз Лабораториз Инк (Фирма) Способ получени производных хромона
US4029493A (en) 1973-02-23 1977-06-14 Mobil Oil Corporation Substituted phenoxybenzonitriles as herbicides
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
FR2397387A1 (fr) 1976-04-27 1979-02-09 Serobiologiques Lab Sa 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes
US4234595A (en) 1977-07-13 1980-11-18 Mead Johnson & Company 3-Indolyl-tertiary butylaminopropanols
DE2862100D1 (en) 1977-10-12 1983-01-05 Ici Plc Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them
DD150456A5 (de) 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
US4567201A (en) 1981-11-25 1986-01-28 Takeda Chemical Industries, Ltd. Diphenoxypropane derivatives and compositions of antiasthmatic and antiinflammatory agents thereof
GB8504093D0 (en) 1985-02-18 1985-03-20 Ici Plc Alkene alkyne/cycloalkylene derivatives
EP0100172B1 (fr) 1982-07-23 1987-08-12 Imperial Chemical Industries Plc Dérivés d'amides
EP0107759B1 (fr) 1982-08-26 1992-12-16 MERCK PATENT GmbH Dérivés du cyclohexane et leur application comme components de cristaux liquides
JPS59144747A (ja) 1983-02-04 1984-08-18 Chisso Corp ２−クロロ−４−アルキルオキシベンゾニトリル化合物
US4536321A (en) 1983-02-18 1985-08-20 Chisso Corporation Fluorobenzene derivatives and liquid crystal compositions containing the same
DE3515633A1 (de) 1985-05-02 1986-11-06 Merck Patent Gmbh, 6100 Darmstadt Benzonitrile
PH23700A (en) 1985-10-01 1989-09-27 Ciba Geigy Ag Microbicides
JPS63141967A (ja) 1986-11-21 1988-06-14 エイ・エッチ・ロビンス・カンパニー・インコーポレーテッド 抗アレルギー薬として有用な１−アリールオキシー４−［（４−アリール）−１−ピペラジニル］−２−ブタノール
JPS63227502A (ja) 1987-03-17 1988-09-21 Sds Biotech Kk 防菌防カビ剤
US4992433A (en) 1987-11-23 1991-02-12 Janssen Pharmaceutica N.V. Novel pyridazinamine derivatives
US4925590A (en) 1988-03-10 1990-05-15 Merck Patent Gesellschaft Mit Beschrankter Haftung Derivatives of 4-cyano-2,3-difluorophenol
DE3825170A1 (de) 1988-07-23 1990-01-25 Hoechst Ag Substituierte 5-(4-(4,5-dihydro-2-oxazolyl)-phenoxyalkylenoxyalkyl)-isoxazole, verfahren sowie 5-(phenoxyalkylenoxyalkyl)-isoxazole als zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von krankheiten, die durch infektion mit viren hervorgerufen wurden
NZ234842A (en) 1989-08-10 1992-06-25 Glaxo Inc Pyridazinone derivatives and pharmaceutical compositions
US5051431A (en) 1989-09-22 1991-09-24 Glaxo Inc. Pyridone nitriles useful in treating cardiovascular disease
DE4017019A1 (de) 1990-05-26 1991-11-28 Hoechst Ag Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen
JPH04124183A (ja) 1990-09-14 1992-04-24 Mitsubishi Rayon Co Ltd 光学活性パントラクトン誘導体
GB9025828D0 (en) 1990-11-28 1991-01-09 Shell Int Research Herbicidal carboxamide derivatives
JP3088777B2 (ja) 1991-03-27 2000-09-18 富士薬品工業株式会社 新規光学分割剤及びそれを用いる光学活性アミンの製造方法
US5320825A (en) 1991-05-01 1994-06-14 Trustees Of The University Of Pennsylvania Serotonin reuptake inhibitors for S.P.E.C.T. imaging
JP3151929B2 (ja) 1992-05-15 2001-04-03 大日本インキ化学工業株式会社 フルオロシクロヘキセン誘導体
DE4217928A1 (de) 1992-05-30 1993-12-02 Hoechst Ag Neue Mischungen aus Herbiziden und Antidots, neue (Hetero-)Aryloxy-Verbindungen, Verfahren zu deren Herstellung, diese enthaltenden Mittel und deren Verwendung
JPH0641038A (ja) 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
EP0659047A1 (fr) 1992-09-09 1995-06-28 E.I. Du Pont De Nemours And Company Composes de benzene herbicides
US5455274A (en) 1992-12-09 1995-10-03 Ciba-Geigy Corporation Hydroxyamidine derivatives
US5326553A (en) 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5316755A (en) 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
GB2278054A (en) 1993-05-18 1994-11-23 Zeneca Ltd Compounds for the treatment of urinary incontinence
GB9321162D0 (en) 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents
DE4339863A1 (de) 1993-11-23 1995-05-24 Bayer Ag Substituierte Carbamoyltriazole
TW262553B (fr) 1994-03-17 1995-11-11 Hitachi Seisakusyo Kk
CA2187019A1 (fr) 1994-04-21 1995-11-02 Stephen B. Ruddy Compositions de contraste radiologique contenant des argiles acceptables sur le plan pharmacologique
JPH07309850A (ja) 1994-05-16 1995-11-28 Canon Inc 光学活性化合物、それを含有する液晶組成物、それを有する液晶素子及びそれらを用いた表示方法、表示装置
US5587392A (en) 1994-05-27 1996-12-24 Mochida Pharmaceutical Co., Ltd. Azolyl methyl phenyl derivatives having aromatase inhibitory activity
PT707007E (pt) 1994-10-14 2002-06-28 Merck Patent Gmbh Derivados amino(tio)eter como agentes activos no snc
JP3802581B2 (ja) 1995-03-01 2006-07-26 富山化学工業株式会社 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤
JPH08325154A (ja) 1995-03-31 1996-12-10 Mitsui Toatsu Chem Inc 安息香酸誘導体およびそれを有効成分として含有するホスホリパーゼａ２阻害剤
DE19534209A1 (de) 1995-09-15 1997-03-20 Jenapharm Gmbh Hormonales Mittel zur Behandlung der Haut
US5843983A (en) 1996-02-15 1998-12-01 Sankyo Company, Limited Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use
ES2127106B1 (es) 1996-03-21 1999-11-16 Menarini Lab Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.
DE19612032A1 (de) 1996-03-27 1997-10-09 Basf Ag Substituierte 1-Methyl-3-benzyluracile
JPH107647A (ja) 1996-06-25 1998-01-13 Yamanouchi Pharmaceut Co Ltd 新規なチオ尿素誘導体又はその塩
US5847166A (en) 1996-10-10 1998-12-08 Massachusetts Institute Of Technology Synthesis of aryl ethers
US6071957A (en) 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US6150390A (en) 1997-02-04 2000-11-21 Dong Wha Pharm. Ind. Co., Ltd. 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof
US6013668A (en) * 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
RU2192412C2 (ru) * 1997-09-18 2002-11-10 Басф Акциенгезельшафт Производные бензамидоксимов, промежуточные продукты, фунгицидные средства, способ борьбы с фитопатогенными грибами
US6297239B1 (en) 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
WO2000034247A2 (fr) 1998-12-04 2000-06-15 Basf Aktiengesellschaft Procede de production de derives de pyrazolylbenzoyl et nouveaux derives de pyrazolylbenzoyl
WO2000034269A1 (fr) 1998-12-09 2000-06-15 American Home Products Corporation Inhibiteurs de thio-uree des virus de l'herpes
US6184249B1 (en) 1998-12-18 2001-02-06 Biophysica, Inc. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
GB9904786D0 (en) 1999-03-02 1999-04-28 Merck Sharp & Dohme Therapeutic agents
WO2000059888A1 (fr) 1999-04-02 2000-10-12 Neurogen Corporation N-benzimidazolylmethyl- et n-indolylmethyl-benzamides et leur application comme modulateurs de corticoliberine
AU2001234689A1 (en) 2000-02-01 2001-08-14 Cor Therapeutics, Inc. Bivalent phenylene inhibitors of factor xa
WO2002006196A1 (fr) 2000-07-13 2002-01-24 Merck Patent Gmbh Composes chiraux i
IL154343A0 (en) 2000-08-31 2003-09-17 Pfizer Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
GB0021670D0 (en) 2000-09-04 2000-10-18 Astrazeneca Ab Chemical compounds
ES2321693T3 (es) 2000-09-06 2009-06-10 Emisphere Technologies, Inc. Compuestos de acido cianofenoxi carboxilico y composiciones para la administracion de agentes activos.
WO2002030891A1 (fr) 2000-10-06 2002-04-18 Tanabe Seiyaku Co., Ltd. Composes aliphatiques azotes a noyau a cinq elements
US20050010048A1 (en) 2000-10-12 2005-01-13 Linghang Zhuang Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors
JP2004517072A (ja) 2000-11-24 2004-06-10 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー Ｃｎｓ障害の治療において有用な化合物
WO2002057215A2 (fr) 2001-01-16 2002-07-25 Theravance, Inc. Modulateurs de canaux de sodium
NZ526531A (en) 2001-01-31 2005-02-25 Pfizer Prod Inc Ether derivatives useful as inhibitors of phosphodiesterase type IV (PDE4) isozymes
DE10110438A1 (de) 2001-03-05 2002-09-19 Bayer Ag Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DK1762567T3 (da) 2001-04-10 2012-06-25 Pfizer Pyrazolderivater til behandling af HIV
AR035700A1 (es) 2001-05-08 2004-06-23 Astrazeneca Ab Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
DE10126434A1 (de) 2001-05-31 2002-12-05 Bayer Ag Thiochromenone
GB0202679D0 (en) 2002-02-05 2002-03-20 Glaxo Group Ltd Novel compounds
ATE518537T1 (de) 2002-02-07 2011-08-15 Univ Tennessee Res Foundation Selective androgen-rezeptor-modulatoren (sarms) für die behandlung der benignen prostatahyperplasie
TW200302722A (en) 2002-02-13 2003-08-16 Astrazeneca Ab Therapeutic agents
CN1633287A (zh) 2002-02-15 2005-06-29 恩多研究公司 联苯衍生物及其作为抗雄激素试剂的应用
WO2003074473A2 (fr) 2002-02-28 2003-09-12 University Of Tennessee Research Foundation Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes
EP1490317A1 (fr) 2002-03-26 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. Mimetiques du glucocorticoide, procedes de fabrication de ces mimetiques, compositions pharmaceutiques et leurs utilisations
EP1348433A1 (fr) 2002-03-28 2003-10-01 Warner-Lambert Company LLC Thiazol-2-yl-imines comme inhibiteurs de la PDE7
EP1348701A1 (fr) 2002-03-28 2003-10-01 Warner-Lambert Company LLC Thiazol-5-yl-amines 2,4-disubstituées comme inhibiteurs de la PDE7
US6875438B2 (en) 2002-04-27 2005-04-05 Aventis Pharma Deutschland Gmbh Preparations for topical administration of substances having antiandrogenic activity
DE10218963A1 (de) * 2002-04-27 2003-11-20 Aventis Pharma Gmbh Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
US6951884B2 (en) 2002-06-12 2005-10-04 Hoffmann-La Roche Inc. Fluorobenzamides and uses thereof
CA2495484A1 (fr) 2002-08-14 2004-03-04 Ciba Specialty Chemicals Holdings Inc. Afficheur a cristaux liquides et filtre couleur presentant une transparence amelioree a la lumiere verte
WO2004018386A2 (fr) 2002-08-26 2004-03-04 Merck & Co., Inc. Potentialisateurs acetophenones des recepteurs metabotropiques du glutamate
JP2006527757A (ja) 2003-06-18 2006-12-07 ファイザー・プロダクツ・インク 新規なピペラジニル−アリールオキシ−ｎ−アリールラクタムおよびピペラジニル−ヘテロアリールオキシ−ｎ−アリールラクタム
FI20030958A0 (fi) 2003-06-27 2003-06-27 Orion Corp Uusia yhdisteitä
JP4874965B2 (ja) 2004-07-08 2012-02-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲン調節剤
TW200708499A (en) * 2005-06-22 2007-03-01 Warner Lambert Co Process for producing ethers

Also Published As

Publication number Publication date
JP2007522199A (ja) 2007-08-09
AU2005214167B2 (en) 2008-08-07
TW200534842A (en) 2005-11-01
WO2005080320A1 (fr) 2005-09-01
JP3997255B2 (ja) 2007-10-24
IL176935A0 (en) 2006-12-10
AP2006003700A0 (en) 2006-08-31
CR8555A (es) 2006-10-17
NO20064053L (no) 2006-11-08
CA2554696C (fr) 2009-06-30
KR20060116223A (ko) 2006-11-14
CA2554696A1 (fr) 2005-09-01
US7576128B2 (en) 2009-08-18
PE20051168A1 (es) 2006-02-18
EP1716110A1 (fr) 2006-11-02
PA8623501A1 (es) 2005-08-30
AU2005214167A1 (en) 2005-09-01
US20050182132A1 (en) 2005-08-18
UY28746A1 (es) 2005-09-30
EA200601267A1 (ru) 2006-12-29
BRPI0507670A (pt) 2007-07-17
EA009902B1 (ru) 2008-04-28
KR100783255B1 (ko) 2007-12-06
ECSP066761A (es) 2006-11-16
AR047606A1 (es) 2006-01-25

Similar Documents

Publication Publication Date Title
MA28361A1 (fr) Modulateurs des recepteurs d'androgenes
DK2031063T3 (da) Modulatorer af duftreceptorer
IL179526A0 (en) Modulators of muscarinic receptors
ATE416168T1 (de) Modulatoren des vanilloidrezeptors
IL176215A0 (en) Modulators of muscarinic receptors
IL181388A0 (en) Modulators of muscarinic receptors
MA28902B1 (fr) Agonistes des recepteurs beta2 adrenergiques diaminiques
EP1773337A4 (fr) Modulateurs de recepteurs nucleaires
ZA200806028B (en) Modulators of muscarinic receptors
ATE497953T1 (de) Thiazolderivate als modulatoren des cannabinoidrezeptors
DK1778618T3 (da) Syntese af triethylentetraminer
ATE545631T1 (de) N-(2-benzyl)-2-phenylbutanamide als androgenrezeptormodulatoren
ZA200606661B (en) Modulation of peroxisome proliferation-activated receptors
EP1734964A4 (fr) 17 beta-acetamide-4-azasteroides utilises en tant que modulateurs du recepteur des androgenes
DK1763520T3 (da) Anvendelse af trisubstituerede benzopyranoner
FR2871145B1 (fr) Distributeur d'applicateurs
CR9144A (es) Formulaciones de benzoxazoles sustituidos
ZA200705116B (en) Modulators of muscarinic receptors
IS8321A (is) Stöðug afbrigði tegaseródvetnismaleats
NO20043305D0 (no) Preparation of lodixanol
MA28368A1 (fr) Modulateurs oxydecahydronaphtalene de hm74
MA28812B1 (fr) Combinaisons d'epothilone
FR2877833B1 (fr) Correcteur de lordoses
DK1730109T3 (da) Syntese af pyrrol-2-carbonitriler
FR2895710B1 (fr) Monopode d'arrimage pour brancard